blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1658068

EP1658068 - NOVEL CYCLOALKYL[B] CONDENSED INDOLES [Right-click to bookmark this link]
Former [2006/21]NOVEL CYCLOALKYL'B! CONDENSED INDOLES
[2008/41]
StatusNo opposition filed within time limit
Status updated on  25.12.2009
Database last updated on 13.07.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza P.O. Box 7929
Philadelphia, PA 19101 / US
[2009/08]
Former [2006/21]For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza, P.O. Box 7929
Philadelphia, Pennsylvania 19101 / US
Inventor(s)01 / BOGGS, Sharon Davis, GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
02 / CATALANO, John G., GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
03 / GUDMUNDSSON, Kristjan S., GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
04 / RICHARDSON, Leah D'Aurora, GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
05 / SEBAHAR, Paul Richard, GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
 [2006/21]
Representative(s)Florence, Julia Anne, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2006/21]Florence, Julia Anne, et al
GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date04754553.807.06.2004
[2006/21]
WO2004US17982
Priority number, dateUS20030497845P26.08.2003         Original published format: US 497845 P
[2006/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005023245
Date:17.03.2005
Language:EN
[2005/11]
Type: A1 Application with search report 
No.:EP1658068
Date:24.05.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 17.03.2005 takes the place of the publication of the European patent application.
[2006/21]
Type: B1 Patent specification 
No.:EP1658068
Date:18.02.2009
Language:EN
[2009/08]
Search report(s)International search report - published on:EP17.03.2005
ClassificationIPC:A61K31/404, A61K31/4045, A61P31/12, A61P35/00, C07D209/88
[2006/21]
CPC:
C07D209/80 (EP,US); A61K31/404 (EP,US); A61K31/4045 (EP,US);
A61P1/00 (EP); A61P15/00 (EP); A61P17/00 (EP);
A61P31/12 (EP); A61P35/00 (EP); C07D209/88 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/21]
Extension statesALNot yet paid
HR16.03.2006
LT16.03.2006
LV16.03.2006
MKNot yet paid
TitleGerman:CYCLOALKYL[B] KONDENSIERTE INDOLE[2008/41]
English:NOVEL CYCLOALKYL[B] CONDENSED INDOLES[2008/41]
French:NOUVEAUX INDOLES CYCLOALKYL[B] CONDENSES[2008/41]
Former [2006/21]CYCLOALKYL'B! KONDENSIERTE INDOLE
Former [2006/21]NOVEL CYCLOALKYL'B! CONDENSED INDOLES
Former [2006/21]NOUVEAUX INDOLES CYCLOALKYL'B! CONDENSES
Entry into regional phase16.03.2006National basic fee paid 
16.03.2006Designation fee(s) paid 
16.03.2006Examination fee paid 
Examination procedure16.03.2006Examination requested  [2006/21]
26.04.2007Despatch of a communication from the examining division (Time limit: M06)
24.10.2007Reply to a communication from the examining division
18.09.2008Communication of intention to grant the patent
12.12.2008Fee for grant paid
12.12.2008Fee for publishing/printing paid
Opposition(s)19.11.2009No opposition filed within time limit [2010/04]
Fees paidRenewal fee
27.03.2006Renewal fee patent year 03
08.06.2007Renewal fee patent year 04
18.03.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.02.2009
CY18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
TR18.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
IE07.06.2009
LU07.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
PT27.07.2009
HU19.08.2009
[2011/44]
Former [2011/32]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
IE07.06.2009
LU07.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
PT27.07.2009
HU19.08.2009
Former [2011/21]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
IE07.06.2009
LU07.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
PT27.07.2009
Former [2010/50]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
IE07.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
PT27.07.2009
Former [2010/21]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
BG18.05.2009
SE18.05.2009
IE07.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
PT27.07.2009
Former [2010/10]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
BG18.05.2009
SE18.05.2009
MC30.06.2009
PT27.07.2009
Former [2010/07]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
SE18.05.2009
MC30.06.2009
PT27.07.2009
Former [2009/51]AT18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
SE18.05.2009
PT27.07.2009
Former [2009/46]AT18.02.2009
DK18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
SI18.02.2009
SE18.05.2009
Former [2009/41]AT18.02.2009
FI18.02.2009
NL18.02.2009
PL18.02.2009
SI18.02.2009
SE18.05.2009
Former [2009/36]FI18.02.2009
NL18.02.2009
SI18.02.2009
Former [2009/35]NL18.02.2009
Cited inInternational search[X]WO0143741  (UNIV ARIZONA [US], et al) [X] 1,2,25 * abstract * * page 3, line 1 - page 4, line 14 * * page 7, line 1 - page 9, line 5 * * page 11, line 3 - page 12, line 17 * * table 4 * * page 34, line 5 - page 39, line 12 *;
 [X]US2003139609  (SKIBO EDWARD B [US], et al) [X] 1,2,25 * abstract *;
 [XP]US2004006054  (SKIBO EDWARD B [US], et al) [XP] 1,2,25 * abstract * * paragraphs [0015] - [0017] *;
 [XP]US2004009613  (ZHOU MING-MING [US], et al) [XP] 1-3,9,10,23 * abstract ** paragraph [0064] *;
 [X]  - XING, CHENGGUO ET AL, "Design of Cancer -Specific Antitumor Agents Based on Aziridinylcyclopent[b]indoloquinones", JOURNAL OF MEDICINAL CHEMISTRY , 43(3), 457-466 CODEN: JMCMAR; ISSN: 0022-2623, (2000), XP008037525 [X] 1,2,25 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm990466w
 [X]  - SKIBO, EDWARD B. ET AL, "Aziridinyl Quinone Antitumor Agents Based on Indoles and Cyclopent[b]indoles: Structure-Activity Relationships for Cytotoxicity and Antitumor Activity", JOURNAL OF MEDICINAL CHEMISTRY , 44(22), 3545-3562 CODEN: JMCMAR; ISSN: 0022-2623, (2001), XP008037527 [X] 1,25 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm010085u
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.